Publication | Closed Access

Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: A randomised controlled 6-week trial

Oral Mmp-9Clinical TrialsPulmonary PharmacologyPulmonary MedicinePharmacotherapyMedicine6-Week TrialModerate-to-severe CopdPulmonary Disease